CD8A and central nervous system cancer: Other cytokines have also been used, including FMS-like tyrosine kinase 3 ligand (Flt3L), which is associated with increases in intratumoral dendritic cells and CD8+ T cells [80,81] and improves survival in glioma-bearing mice [82].